160 related articles for article (PubMed ID: 37863464)
1. Comparison of estrogenic components used for hormonal contraception.
Stanczyk FZ; Winer SA; Foidart JM; Archer DF
Contraception; 2024 Feb; 130():110310. PubMed ID: 37863464
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
Douxfils J; Klipping C; Duijkers I; Kinet V; Mawet M; Maillard C; Jost M; Rosing J; Foidart JM
Contraception; 2020 Dec; 102(6):396-402. PubMed ID: 32956694
[TBL] [Abstract][Full Text] [Related]
3. Oestrogens in oral contraception: considerations for tailoring prescription to women's needs.
Fruzzetti F; Fidecicchi T; Gambacciani M
Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):93-102. PubMed ID: 38683756
[TBL] [Abstract][Full Text] [Related]
4. Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
Duijkers I; Klipping C; Kinet V; Jost M; Bastidas A; Foidart JM
Contraception; 2021 Jun; 103(6):386-393. PubMed ID: 33689786
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of contraceptive steroids.
Sitruk-Ware R; Nath A
Rev Endocr Metab Disord; 2011 Jun; 12(2):63-75. PubMed ID: 21538049
[TBL] [Abstract][Full Text] [Related]
6. Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
Mawet M; Maillard C; Klipping C; Zimmerman Y; Foidart JM; Coelingh Bennink HJ
Eur J Contracept Reprod Health Care; 2015; 20(6):463-75. PubMed ID: 26212489
[TBL] [Abstract][Full Text] [Related]
7. Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
Klipping C; Duijkers I; Mawet M; Maillard C; Bastidas A; Jost M; Foidart JM
Contraception; 2021 Apr; 103(4):213-221. PubMed ID: 33428907
[TBL] [Abstract][Full Text] [Related]
8. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
Kangasniemi MH; Arffman RK; Joenväärä S; Haverinen A; Luiro K; Tohmola T; Renkonen R; Heikinheimo O; Tapanainen JS; Piltonen TT
Hum Reprod; 2023 Jan; 38(1):89-102. PubMed ID: 36416543
[TBL] [Abstract][Full Text] [Related]
9. Estetrol: A New Choice for Contraception.
Fruzzetti F; Fidecicchi T; Montt Guevara MM; Simoncini T
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884326
[TBL] [Abstract][Full Text] [Related]
10. [Combined Hormonal Contraception - Which Pill for Which Patient?].
Quaas P
Praxis (Bern 1994); 2023; 112(4):205-210. PubMed ID: 36919319
[TBL] [Abstract][Full Text] [Related]
11. Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
Bauerfeind A; von Stockum S; Boehnke T; Heinemann K
Obstet Gynecol; 2024 Mar; 143(3):431-434. PubMed ID: 38227942
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
[TBL] [Abstract][Full Text] [Related]
13. Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive.
Nelson AL
Expert Opin Pharmacother; 2023; 24(16):1757-1764. PubMed ID: 37691580
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
Duijkers IJ; Klipping C; Zimmerman Y; Appels N; Jost M; Maillard C; Mawet M; Foidart JM; Coelingh Bennink HJ
Eur J Contracept Reprod Health Care; 2015; 20(6):476-89. PubMed ID: 26394847
[TBL] [Abstract][Full Text] [Related]
15. A novel estetrol-containing combined oral contraceptive: European expert panel review.
Gemzell-Danielsson K; Cagnacci A; Chabbert-Buffet N; Douxfils J; Foidart JM; Kubba A; Lete Lasa LI; Mansour D; Neulen J; Neves J; Palma F; Römer T; Spaczyński R; Tóth V
Eur J Contracept Reprod Health Care; 2022 Oct; 27(5):373-383. PubMed ID: 35862627
[TBL] [Abstract][Full Text] [Related]
16. Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications.
Battipaglia C; Feliciello L; Genazzani AD; Facchinetti F; Grandi G
Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):871-879. PubMed ID: 37942662
[TBL] [Abstract][Full Text] [Related]
17. A novel estetrol-containing combined oral contraceptive: European expert panel review.
Gemzell-Danielsson Kristina; Cagnacci Angelo; Chabbert-Buffet Nathalie; Douxfils Jonathan; Foidart Jean-Michel; Kubba Ali; Lasa Luis Ignacio Lete; Mansour Diana; Neulen Joseph; Neves Jaoquim; Palma Fátima; Römer Thomas; Ski Robert Spaczy; Tóth Vera
Ceska Gynekol; 2022; 87(6):440-452. PubMed ID: 36543594
[TBL] [Abstract][Full Text] [Related]
18. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
Haverinen AH; Luiro KM; Szanto T; Kangasniemi MH; Hiltunen L; Sainio S; Piltonen TT; Lassila R; Tapanainen JS; Heikinheimo O
Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1102-1111. PubMed ID: 35909329
[TBL] [Abstract][Full Text] [Related]
19. Estetrol (E4): the new estrogenic component of combined oral contraceptives.
Grandi G; Del Savio MC; Lopes da Silva-Filho A; Facchinetti F
Expert Rev Clin Pharmacol; 2020 Apr; 13(4):327-330. PubMed ID: 32238069
[No Abstract] [Full Text] [Related]
20. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
Coelingh Bennink HJT; Zimmerman Y; Laan E; Termeer HMM; Appels N; Albert A; Fauser BCJM; Thijssen JHH; van Lunsen RHW
Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
